Mind Medicine (MindMed) Inc.
MMED
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.70M | 7.60M | 9.81M | 10.50M | 10.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.46M | 24.79M | 24.46M | 22.20M | 22.21M |
| Operating Income | -32.46M | -24.79M | -24.46M | -22.20M | -22.21M |
| Income Before Tax | -34.74M | -13.68M | -5.85M | -54.40M | -23.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.74M | -13.68M | -5.85M | -54.40M | -23.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.74M | -13.68M | -5.85M | -54.40M | -23.86M |
| EBIT | -32.46M | -24.79M | -24.46M | -22.20M | -22.21M |
| EBITDA | -32.46M | -24.79M | -24.46M | -22.18M | -- |
| EPS Basic | -0.41 | -0.18 | -0.08 | -1.14 | -0.59 |
| Normalized Basic EPS | -0.26 | -0.11 | -0.07 | -0.71 | -0.37 |
| EPS Diluted | -0.42 | -0.27 | -0.26 | -1.14 | -0.60 |
| Normalized Diluted EPS | -0.26 | -0.11 | -0.07 | -0.71 | -0.37 |
| Average Basic Shares Outstanding | 83.93M | 77.91M | 71.91M | 47.86M | 40.23M |
| Average Diluted Shares Outstanding | 83.93M | 80.24M | 75.30M | 47.86M | 40.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |